Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Desmoplastic Small Round Cell Tumor · Osteosarcoma · Recurrent Desmoplastic Small Round Cell Tumor · Recurrent Kidney Wilms Tumor · Recurrent Osteosarcoma · Refractory Desmoplastic Small Round Cell Tumor · Refractory Wilms Tumor · Wilms Tumor

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Children's Hospital of Alabama, Birmingham, Alabama, United States

  • Children's Hospital Los Angeles, Los Angeles, California, United States

  • Children's Hospital of Orange County, Orange, California, United States

  • Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States

  • UCSF Medical Center-Mission Bay, San Francisco, California, United States

  • Children's Hospital Colorado, Aurora, Colorado, United States

  • Children's National Medical Center, Washington D.C., District of Columbia, United States

  • Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · Olivia.Floyd@choa.org · 404-785-0232
    Contact: Principal Investigator (Jason R. Fangusaro)
  • Lurie Children's Hospital-Chicago, Chicago, Illinois, United States

  • Riley Hospital for Children, Indianapolis, Indiana, United States

  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

  • C S Mott Children's Hospital, Ann Arbor, Michigan, United States

  • University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States

  • Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States

  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Shalini Shenoy)
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Julia L. Glade Bender)
  • Duke University Medical Center, Durham, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-275-3853
    Contact: Principal Investigator (Jessica M. Sun)
  • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States

  • Saint Jude Children's Research Hospital, Memphis, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · referralinfo@stjude.org · 888-226-4343
    Contact: Principal Investigator (Jessica Gartrell)
  • Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States

  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States

  • Primary Children's Hospital, Salt Lake City, Utah, United States

מובילי המחקר
  • Damon R Reed

    Principal Investigator

    Pediatric Early Phase Clinical Trial Network